Escient Pharmaceuticals is a privately held biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications.

Biotechnology

Escient Pharmaceuticals

Michelle Solomon PhD

David Houck

Veena Viswanath

Terri Kim

Christian Weyer

Marion Lanier

Tonya Haugen

Jennifer Brooks

Research and Development

Administration and Support

Clinical and Regulatory Affairs

Leadership Team

Biometrics and Data Analytics

Finance and Accounting

Teams at Escient Pharmaceuticals